Tr1X
PrivateLast Round
Grant
Jun 25, 2026
Total Funding Raised
$78M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tr1X is a biotechnology company developing off-the-shelf allogeneic regulatory T cell therapies to treat autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tr1X Comparables
Compare Tr1X with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 87% | |
| Cellenkos, Inc. | 86% | |
| Sonoma Biotherapeutics | 84% | |
Tr1X Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 25, 2026 | ||||
| Series B | Oct 14, 2025 | ||||
| Grant | Apr 4, 2025 | ||||
| Grant | Jan 1, 2024 |
Tr1X Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Grant |
| Neva SGR | Grant, Series B |
| The Chernin Group | Grant |
| California Institute for Regenerative Medicine | Grant |
| Alexandria Venture Investments | Grant, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Received $8M grant from California Institute for Regenerative Medicine.
- Apr 27, 2026
New data on Engineered Tr1 Treg cell therapies to be presented at ASGCT 2026.
Tr1X Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tr1X's valuation, stock price, and market status.